Aligning the NMC with India's Healthcare Goal
NMC
) in the year 2020 marked a pivotal moment in the evolution of medical education in India. It was envisioned to be a contemporary regulator to support quality education, foster
ethical standards
, and align with the aspirations of the medical profession and the healthcare needs of the country.
Replacing the Medical Council of India (MCI)—which had long guided Indian medical education and professional standards—the NMC was expected to introduce reform and usher in greater transparency, improved governance, and forward-looking reforms suited to contemporary challenges.
While it may still be too early for a comprehensive judgment, initial assessments by the medical community and public health professionals suggest that much more needs to be done and with a greater sense of urgency.
The Commission continues to face significant structural and operational hurdles. A considerable number of key posts within the NMC and its affiliated boards remain vacant, slowing decision-making and limiting the ability to implement essential reforms.
One recurring concern is the process of inspection and accreditation of medical colleges. Many
medical institutions
report that inspection periods are times of great uncertainty and stress. It is widely known that irregularities and inefficiencies influence outcomes.
Such situations, if left unaddressed, have far reaching implications not only for institutions but also for the students they graduate, and ultimately for the quality of care delivered across India's healthcare system.
Among the most ambitious proposals under the NMC was the
National Exit Test
(NEXT)—a single exam intended to serve as the final
MBBS
examination, a licensure requirement, and an entrance to postgraduate studies rolled into one. It was designed with the aim to bring uniformity, fairness, and accountability into the system. However, its implementation has been delayed.
A well-structured and efficiently conducted NEXT exam could serve as a valuable tool to evaluate both students and the institutions they graduate from. It would also offer a transparent mechanism to ensure consistency in educational outcomes nationwide. There is still time to re-energize this initiative and make it a cornerstone of quality assurance.
The
National Board of Examinations
(NBE), which provides another stream of
postgraduate medical education
, offers a successful example of what autonomy and focused leadership can achieve.
Over the years, the NBE has built a strong reputation for transparency, efficiency, and academic integrity. Its examination processes, institutional assessments, and stakeholder engagement practices are generally seen as reliable, consistent, and forward-thinking.
The NBE's success lies in its operational autonomy, professional governance, and adoption of technology-enabled systems. Its model of functioning—free from excessive bureaucracy and driven by meritocratic principles—can offer valuable lessons to the NMC. Adapting similar frameworks could help the NMC address long-standing challenges and deliver on its mandate more effectively.
At a time when digital tools and artificial intelligence are transforming every sector, medical regulation must also evolve. Modern technology can enable continuous, real-time monitoring of key indicators such as hospital load, faculty strength, patient volumes, teaching hours, and student attendance.
This offers a compelling alternative to traditional manual inspections. A transparent, data-driven, and technology-enabled system would reduce the burden on institutions, promote consistency, and significantly limit the scope for subjectivity or error. The NMC now has a tremendous opportunity to pioneer such systems and set a new benchmark for regulatory practices in the healthcare education sector.
To achieve its full potential, the NMC must be strengthened structurally. One important step is to ensure that its members are individuals with deep professional knowledge and experience, drawn from the highest levels of medical education, clinical practice, public health, and institutional governance.
The post of Secretary, in particular, requires urgent attention. This critical role should not be treated as a routine administrative appointment but rather entrusted to someone with adequate domain expertise, as is done with the Executive Director of the NBE.
In the case of the NBE, the Executive Director is selected through a search-and-selection committee comprising reputed medical professionals—ensuring both legitimacy and professional competence.
A similar process should be instituted for the NMC Secretary. At present, the role risks being reduced to bureaucratic oversight and staff management, rather than leading key academic and regulatory functions. Given the complex, technical decisions required, the Secretary must be empowered with the knowledge, independence, and stature necessary to lead with credibility and vision.
Just as essential is granting the NMC the operational autonomy it needs to implement reforms with confidence and agility. Within a framework of accountability, the Commission must be empowered to take independent action in the interest of the profession and public health. Without this, reform efforts will remain fragmented, and trust among stakeholders will be difficult to restore.
India's healthcare landscape is evolving rapidly. With rising demand for quality care, equitable access, and well-trained professionals, our regulatory systems must be ready to support innovation, ethics, and excellence.
The medical community feels that there is an urgent need to recalibrate and strengthen the NMC. With the right leadership, enhanced autonomy, and a commitment to transparency, the NMC can fulfil the role it was created for: an enabler of quality education, professional integrity, and system-wide trust.
The future of India's healthcare workforce depends on the institutions that educate and regulate them. By embracing thoughtful reform, leveraging technology, and drawing lessons from successful models like the NBE, the NMC can still emerge as a catalyst for national progress.
The decision-makers must ensure that the NMC lives up to its promise: to serve students, empower educators, guide institutions, and ultimately, secure the health and well-being of the people of India.
The article is written by Dr Alexander Thomas Founder Patron, AHPI, ANBAI, CAHO and and Prof. O. V. Nandimath Prof. at National Law School of India University [NLSIU], Bangalore.
(DISCLAIMER: The views expressed are solely of the author and ETHealthworld.com does not necessarily subscribe to it. ETHealthworld.com shall not be responsible for any damage caused to any person/organisation directly or indirectly)
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hindu
43 minutes ago
- The Hindu
Experts call for inclusion of Chronic Kidney Disease in national NCD programme
Hyderabad-based dialysis care network, NephroPlus, has urged policymakers to include Chronic Kidney Disease (CKD) screening in India's flagship National Programme for Prevention and Control of Non-Communicable Diseases (NP-NCD), as it released a white paper highlighting the rising burden of CKD across India and neighbouring countries. Speaking at a media briefing in Hyderabad on Tuesday, NephroPlus Group CEO Rohit Singh said the findings of the white paper and a large-scale screening initiative make a strong case for integrating CKD testing, particularly serum creatinine and urine albumin-to-creatinine ratio (ACR), into existing government-led screenings for hypertension and diabetes. 'The burden is silent but severe. CKD needs to be part of India's NCD strategy immediately,' he said. The paper is based on data from a kidney health screening campaign conducted in the lead-up to World Kidney Day in March. The campaign spanned 30 locations across India, the Philippines, and Uzbekistan, and covered 12 Indian States. A total of 10,501 persons pledged for kidney health awareness, of whom more than 5,000 underwent free serum creatinine and estimated glomerular filtration rate (eGFR) tests. NephroPlus found that several Indian States reported high prevalence of CKD risk factors. Jharkhand topped the list, followed by Haryana and Uttarakhand, Andhra Pradesh, Bihar, Delhi, Karnataka, Maharashtra, Uttar Pradesh, Telangana, Gujarat and Rajasthan. NephroPlus co-founder Kamal D. Shah stressed the economic and emotional toll of dialysis. 'Dialysis is not just a treatment; it is a lifelong ordeal that drains families physically, emotionally and financially. Our data shows that investing ₹1 in prevention saves ₹10 to ₹15 in future dialysis costs,' he said.
Time of India
an hour ago
- Time of India
IMA Nagpur Protests MMC Move Allowing Homeopaths To Register As Allopaths
1 2 3 Nagpur: A joint delegation of doctors led by the Indian Medical Association (IMA), Nagpur, submitted a memorandum to the chief minister through the district collector's office, strongly opposing a recent decision of the Maharashtra Medical Council (MMC) allowing homeopathic doctors to register as allopathic practitioners. The representation was handed over to Anup Khande, resident district collector (RDC), Nagpur. The memorandum, signed by IMA Nagpur president Dr Rajesh Sawarbandhe and secretary Dr Jitendra Sahu, warns that the MMC's notification dated June 30, allowing homeopaths who complete a short 'Certificate Course in Modern Pharmacology (CCMP)' to register under MMC, poses a serious threat to public health and patient safety. "The MMC was created exclusively to regulate MBBS and higher qualified allopathic doctors. Permitting lateral entry from a completely different system undermines medical ethics and public trust," the memorandum states. It adds that the one-year CCMP course cannot equate to years of rigorous MBBS education and clinical training. Several other medical associations, including NOGS, AMF, AMS, and the Anaesthesiology Society, also submitted similar memoranda to Khande, highlighting a unified stance from the allopathic fraternity. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like 5 Books Warren Buffett Wants You to Read In 2025 Blinkist: Warren Buffett's Reading List Undo The IMA demanded immediate withdrawal of the notification and warned of a 24-hour withdrawal of non-emergency health services on July 11 if the demand is not met. "We respect homeopathy as a separate system. But mixing regulatory frameworks is unsafe and unacceptable," the doctors stressed. The delegation urged the chief minister to protect the sanctity of the MMC and ensure that homeopathic doctors continue to be governed by their own council.
Time of India
2 hours ago
- Time of India
Pharma lobby flags 'cumbersome' export rule, seeks change
New Delhi: A significant dip in exports has prompted pharma lobby groups to raise a demand for changing the centralised no-object certification (NOC) provision for drug exports . The provision, which requires pharma companies to seek an approval from the national regulatory agency of the importing country or an NOC from the Indian regulator for shipments, has resulted in a drop in exports and diverted trade to other nations, industry executives told ET. The issue was raised in a meeting held on Monday at Niti Aayog . "Pharma exports have suffered due to the mismatch or an anomaly in newly introduced regulatory standards by the drug regulatory authority of India," said a person who attended the meeting. In early March, the Drugs Controller General of India (DCGI) updated the export NOC checklist in the wake of events such as the controversy over a Mumbai-based drugmaker allegedly exporting addictive opioid drugs to West African nations such as Ghana and Nigeria. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like What the Market May Be Getting Wrong About Nvidia Seeking Alpha Read More Undo However, the stringent norms have started hurting exports, industry insiders said. "Taking approvals from different regulatory bodies has only made the whole process cumbersome," the person cited above said. He noted that medicines are manufactured depending on the patient population construct. Live Events For example, Dolo and other paracetamol tablets are approved in India in strengths of 325mg, 500 mg and 650 mg while in Nigeria, it's approved for a strength of 1,000 mg. To manufacture and export that, Indian drugmakers now require an NOC from Nigerian authorities. The lobby groups have urged the government to review the provision as, according to them, this would divert trade to other nations with less stringent regulations. "Such a condition has imposed an undue burden on Indian exporters, potentially stifling innovation and hindering the export of unapproved/banned products especially for the MSME pharmaceutical sector, which is under tremendous strain with respect to compliance to domestic and international guidelines and trade barriers (tariffs & non-tariffs),' an industry expert said on condition of anonymity. The Niti Aayog had called pharma experts to undertake an analysis of the current state of the industry, to understand the challenges faced by drugmakers and initiatives taken by them to ensure production of safe and effective products. Nikkhil K Masurkar, chief executive of Entod Pharmaceuticals, said the official think tank's call for a quality overhaul is both "timely and necessary." "While India has made remarkable strides as a global pharma hub, maintaining consistent, internationally acceptable quality standards remains a key challenge, especially among MSME companies," he said. "The root of the problem often lies not in intent, but in outdated infrastructure, fragmented regulatory enforcement, and insufficient technical training," Masurkar said. "To produce world-class medicines, we must invest in continuous quality improvement, digitalise compliance systems, and empower our MSME sector with both financial and technical support."
